首页 Avantor, Inc.(usAVTR)-基本信息

Avantor, Inc.(usAVTR)-基本信息

日报更新时间:

周报更新时间:04-18 04:06

行情信息

今开价:31.7

最高价:32.24

成交量:1338526.0

昨收价:31.6

最低价:31.545

最新价:32.2

行情图标
概要信息

英文名称:Avantor, Inc.


行业:工业


简介:Avantor, Inc.于2017年5月在特拉华州注册成立。该公司是为生物制药,医疗保健,教育和政府以及先进技术和应用材料行业的客户提供关键任务产品和服务的全球领先供应商。他们的综合产品……


电话:1-610-3861700


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 持股信息
  • 领导人信息

1904年,Avantor, Inc.以J.T. Baker Chemical Company之名成立,2010年,公司被New Mountain Capital, LLC的附属公司收购,后,公司于2016年和2017年先后收购了NuSil(创立于1985)和VWR(创立于1852年),在收购VWR后,2017年5月,公司以Avantor, Inc.之名重新注册成立。艾万拓公司的综合产品包括材料和消耗品,设备和仪器以及服务和专业采购,公司的客户同场依赖这些产品,因为这些产品经常被指定用于他们的研究、开发和生产过程。艾万拓公司与客户密切合作,使他们能够开发新的创新产品,降低开发和生产成本,改善产品或工艺性能特征,并提高他们生产的药品,设备和其他产品的安全性和可靠性。除了依赖公司的产品外,许多客户还依赖艾万拓公司的服务。Avantor的本地业务与他们的全球基础设施相结合,并促进与客户的成功合作关系,并将公司连接到180多个国家的240,000多个地点。Avantor的使命是推动科学发展,创造一个更美好的世界。艾万拓公司产品组合的深度和广度为公司的客户提供全面的产品和服务,使其能够为客户创建定制的集成解决方案。Avantor在发现,研究,开发和生产过程中向客户销售的精选产品包括: 材料和耗材:超高纯度化学品和试剂,实验室产品和用品,高度专业化的配方硅胶材料,定制辅料,定制一次性组件,工艺色谱树脂和色谱柱,分析样品制备试剂盒以及教育和微生物学和临床试剂盒。2018年,Avantor收入的33%来自专有材料和消耗品的销售,公司收入的40%来自第三方材料和消耗品。 设备和仪器仪表:过滤系统,病毒灭活系统,培养箱,分析仪器,蒸发器,超低温冰柜,生物安全柜和关键环境用品。 服务和专业采购:实验室和生产、临床、设备、采购和生物制药材料的扩大和开发服务。艾万拓公司在为各种工作流程开发,定制,制造和供应产品方面拥有深厚的专业知识,使公司能够在客户产品的整个生命周期内提供量身定制的解决方案。总的来说,Avantor提供约600万种产品,包括公司生产的产品以及全球约4,000家核心供应商的产品。Avantor生产的产品满足或超过了许多高度监管行业客户的苛刻要求。Avantor的高纯度和超高纯度产品,例如其J.T.Baker和SeaStar品牌化学品,受到全球生命科学和电子材料客户的信赖,并且可以按照每万亿分之一的严格纯度进行生产。同样,Avantor的NuSil品牌的高纯度定制有机硅已被领先的医疗设备制造商和航空航天公司信赖了三十多年。在客户工作流程的每一步,艾万拓都会分享公司的科学和工作流程专业知识,以帮助为现有客户产品和流程提供渐进和可持续的改进。 这些项目包括提高产品纯度,从而提高其性能特征,改进产品包装和简化工作流程。 艾万拓的战略计划包括在新兴科学领域开发新产品,如细胞和基因治疗。 还是目前与客户共有约1,400个创新项目,旨在解决现有产品的流程改进以及公司支持的潜在重大新机遇。

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Franklin Advisers, Inc. 840500 0.16% 192500 29.71% 2019-07-31
PGIM Investments LLC 2888998 0.54% -543917 -15.84% 2019-07-31
John Hancock Investment Management LLC 2936430 0.55% 2936430 -- 2019-07-31
BlackRock Advisors LLC 5163365 0.97% -112350 -2.13% 2019-07-31
Vanguard Investments Australia Ltd 6053151 1.13% 2466306 68.76% 2019-07-31
Fidelity SelectCo, LLC 7464000 1.40% 200000 2.75% 2019-07-31
Fidelity Management & Research Company 14774715 2.77% 229847 1.58% 2019-07-31
Teachers Advisors LLC 18812066 3.52% 18812066 -- 2019-07-31
Vanguard Group Inc 19565931 3.66% 7423321 61.13% 2019-07-31
MML Investment Advisers, LLC 2426890 0.45% 2426890 -- 2019-07-31
Invesco Advisers, Inc. 2382384 0.45% 2382384 -- 2019-07-31
Charles Schwab Investment Management Inc 900067 0.17% 9231 1.04% 2019-07-31
Advanced Series Trust 992580 0.19% -- -- 2019-07-31
Voya Investments, LLC 1192661 0.22% 1192661 -- 2019-07-31
Carillon Tower Advisers, Inc. 1579659 0.30% 1579659 -- 2019-07-31
Principal Global Investors, LLC 1639216 0.31% 74996 4.79% 2019-07-31
Robeco Institutional Asset Mgmt BV 1682161 0.31% -28643 -1.67% 2019-07-31
T. Rowe Price 2143160 0.40% 2143160 -- 2019-07-31
Polar Capital LLP 2264049 0.42% 429521 23.41% 2019-07-31
T. Rowe Price Associates, Inc. 30960782 5.79% 30960782 -- 2019-07-31
Penn Mutual Asset Management LLC 603318 0.11% 603318 -- 2019-06-30
T. Rowe Price International Limited 789925 0.15% 929 0.12% 2019-06-30
Transamerica Asset Management, Inc 1630090 0.31% 1623554 24840.18% 2019-06-30
Northern Trust Investments Inc 553891 0.10% 553891 -- 2019-06-30
Hartford Funds Management Company, LLC 494002 0.09% 494002 -- 2019-06-30
Strategic Advisers LLC 490000 0.09% 490000 -- 2019-06-30
Olive Street Investment Advisers, LLC 277111 0.05% 277111 -- 2019-06-30
First Trust Advisors L.P. 304486 0.06% -- -- 2019-06-30
Pacific Life Fund Advisors LLC (PLFA) 333408 0.06% 333408 -- 2019-06-30
BlackRock 453857 0.08% 453857 -- 2019-06-30
K2/D&S Management Co., L.L.C. 191320 0.04% 191320 -- 2019-06-30
BlackRock Fund Advisors 150494 0.03% -- -- 2019-06-30
State Street Global Advisors 11700 -- 11700 -- 2019-06-30
(Junk) Columbia Management Investment Advisers, LLC 31064 0.01% 31064 -- 2019-06-30
Vanguard 34762 0.01% 34762 -- 2019-06-30
Renaissance Capital LLC 63794 0.01% -- -- 2019-06-30
Morningstar Investment Management LLC 136260 0.03% 136260 -- 2019-06-30
Vanguard Investments Canada Inc 499 -- 499 -- 2019-05-31
Barclays Bank PLC 4055 -- 4055 -- 2019-05-31
BlackRock Asset Management Canada Ltd 145628 0.03% -1 -- 2019-05-31
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Invesco American Franchise Fund 1875669 0.33% 1875669 -- 2019-06-30
T. Rowe Price Mid-Cap Growth Fund 11500000 2.02% 11500000 -- 2019-06-30
CREF Growth Account 9001358 1.58% 9001358 -- 2019-05-31
CREF Stock Account 6691222 1.18% 6691222 -- 2019-05-31
T. Rowe Price Institutional Lrg Cp Gr Fd 6640773 1.17% 6640773 -- 2019-06-30
Vanguard Total Stock Market Index Fund 6053151 1.06% 2466306 68.76% 2019-06-30
Vanguard Small Cap Index 5784637 1.02% 2471293 74.59% 2019-06-30
T. Rowe Price Capital Appreciation Fund 4870986 0.86% 4870986 -- 2019-06-30
T. Rowe Price Health Sciences Fund 4398772 0.77% 4398772 -- 2019-06-30
Vanguard Small Cap Growth Index Fund 3314203 0.58% 2376466 253.43% 2019-06-30
Vanguard Extended Market Index Fund 3021543 0.53% 576941 23.60% 2019-06-30
Fidelity 2059800 0.36% 357700 21.02% 2019-06-30
PGIM Jennison Health Sciences Fund 2145569 0.38% -- -- 2019-06-30
MassMutual Select Mid Cap Growth Fund 2192000 0.39% 2192000 -- 2019-06-30
BlackRock Health Sciences Opps Port 2343080 0.41% -- -- 2019-06-30
JHancock Disciplined Value Mid Cap Fund 2549327 0.45% 2549327 -- 2019-05-31
BlackRock Mid-Cap Growth Equity Port 2673741 0.47% -- -- 2019-06-30
T. Rowe Price Instl Mid-Cap Eq Gr Fd 2844000 0.50% 2844000 -- 2019-06-30
Polar Capital Healthcare Opps Fund 1727234 0.32% 1727234 -- 2019-05-31
Fidelity Advisor 1774900 0.33% 1774900 -- 2019-05-31
TIAA-CREF Growth & Income Fund 1372212 0.26% 1372212 -- 2019-05-31
Robeco BP US Premium Equities 1495541 0.28% 1495541 -- 2019-05-31
Carillon Eagle Mid Cap Growth Fund 1579659 0.30% 1579659 -- 2019-06-30
Transamerica Large Cap Value Fund 1625000 0.30% 1625000 -- 2019-05-31
AST T. Rowe Price Large-Cap Growth Port 992580 0.19% 992580 -- 2019-05-31
Vanguard Small Cap Value Index Fund 1050729 0.20% 1050729 -- 2019-05-31
PGIM Jennison Small Company Fund 1287346 0.24% 1287346 -- 2019-05-31
Principal LargeCap Growth Fund I 1370777 0.26% 1370777 -- 2019-05-31
Franklin Small-Mid Cap Growth Fund 575500 0.11% 575500 -- 2019-05-31
Vanguard Health Care Index Fund 463010 0.09% 463010 -- 2019-05-31
Schwab US Mid-Cap ETF 431067 0.08% 197 0.05% 2019-06-28
Hartford Healthcare Fund 420700 0.08% 420700 -- 2019-05-31
First Trust US Equity Opportunities ETF 302323 0.06% 1956 0.65% 2019-06-27
BlackRock Event Driven Equity Fund 258894 0.05% 258894 -- 2019-05-31
Robeco BP US Select Opportunities Eqs 215263 0.04% 215263 -- 2019-05-31
Pacific Select Fund Mid-Cap Value Port 203384 0.04% 203384 -- 2019-05-31
Vanguard Instl Total Stock Market Idx Fd 173952 0.03% 173952 -- 2019-05-31
iShares Core Balanced ETF Portfolio 145454 0.03% -- -- 2019-05-30
Schwab US Large-Cap ETF 133505 0.02% 270 0.20% 2019-05-31
Principal MidCap Growth Fund III 139333 0.03% 139333 -- 2019-05-31
iShares Core S&P Total US Stock Mkt ETF 145454 0.03% -- -- 2019-05-31
iShares Core S&P US Total Market ETF 145454 0.03% -- -- 2019-05-30
Schwab US Large-Cap Growth ETF 111158 0.02% -- -- 2019-05-31
Schwab US Broad Market ETF 105574 0.02% -25 -0.02% 2019-05-31
State Street US Total Market Index Fund 11700 -- 11700 -- 2019-05-31
Aegon Large Cap Value Fund 6536 -- 6536 -- 2019-05-31
GlobalAccess US Small & Mid Cap Eq Fd 4055 -- 4055 -- 2019-05-31
iShares Core S&P US Total Mkt ETF CADH 174 -- -1 -0.57% 2019-05-30
Pacific Select Fund Health Sciences 130024 0.02% 130024 -- 2019-05-31

Rajiv Lochan Gupta Rajiv Lochan Gupta is a businessperson who has been the head of 10 different companies and currently occupies the position of Independent Non-Executive Chairman for Aptiv Plc, Chairman of Delphi Automotive LLP (a subsidiary of Aptiv Plc) and Chairman at Avantor, Inc., Chairman at Avantor Performance Materials, Inc. (a subsidiary of Avantor, Inc.). Mr. Gupta is also on the board of Arconic Defense, Inc., DuPont de Nemours, Inc. and Arconic, Inc. In his past career Mr. Gupta was Lead Independent Director at HP, Inc., Chairman at American Chemistry Council, Inc., Director at Information Resources, Inc., Chairman & Chief Executive Officer of Rohm & Haas Co., Chairman for J.T. Baker Holdings, Inc. and Chairman-American Section at Society of Chemical Industry. Rajiv Lochan Gupta received a graduate degree from Cornell University, an MBA from Drexel University and an undergraduate degree from Indian Institute of Technology Bombay.
Rakesh Sachdev Rakesh Sachdev is a businessperson who has been at the head of 5 different companies. Currently, Mr. Sachdev is Chairman of Regal Beloit Corp. and Chairman of Aceto Corp. Mr. Sachdev is also on the board of 7 other companies. In the past he was Chief Administrative Officer & MD-Emerging Markets at Arvin Innovation, Inc., Executive Director & CFO-Automotive Business Unit at Cummins, Inc. and Chief Financial Officer-Automotive Business Unit at Cummins Engine Co., Inc. (a subsidiary of Cummins, Inc.), President-Asia Pacific at Meritor, Inc. and Senior Vice President & President-Asia Pacific at ArvinMeritor, Inc. (a subsidiary of Meritor, Inc.), President, Chief Executive Officer & Director at Sigma-Aldrich Corp. and President, Chief Executive Officer & Director at Sigma-Aldrich Co. LLC (Missouri). Mr. Sachdev received an undergraduate degree from Indian Institute of Technology New Delhi, a graduate degree from the University of Illinois and an MBA from Kelley School of Business.
Thomas A. Szlosek Presently, Thomas A. Szlosek is Chief Financial Officer & Executive VP for Avantor, Inc. In his past career he occupied the position of Chief Financial Officer & Senior Vice President for Honeywell International, Inc. and CFO-Asian Medical Systems at General Electric Co. He received an undergraduate degree from State University of New York College at Geneseo.
Charles R. Kummeth Presently, Charles R. Kummeth is President, Chief Executive Officer & Director at Bio-Techne Corp. and Chief Executive Officer for Research & Diagnostic Systems, Inc., Chief Executive Officer at ProteinSimple, Inc. and President & Director at CyVek, Inc. (which are all subsidiaries of Bio-Techne Corp.). Charles R. Kummeth is also on the board of 6 other companies. In the past Mr. Kummeth was President-Mass Spectrometry & Chromatography at Thermo Fisher Scientific, Inc. and Vice President-Medical Division at 3M Co. Mr. Kummeth received an undergraduate degree from the University of North Dakota, a graduate degree from the University of St. Thomas (Minnesota) and an MBA from The Curtis L. Carlson School of Management.
Matthew S. Holt Currently, Matthew S. Holt occupies the position of Chairman at Signify Health LLC, Chairman at Convey Health Solutions, Inc., Chairman for CIOX Health LLC, Chairman for Cytel, Inc. and Managing Director at New Mountain Capital LLC. Mr. Holt is also on the board of 6 other companies. He previously occupied the position of Principal at Lehman Brothers Holdings, Inc. He received an undergraduate degree from Harvard College.
Andre V. Moura Presently, Andre V. Moura is Chairman for Topix Pharmaceuticals, Inc. and Chairman of Stearn's Products, Inc. (a subsidiary of Topix Pharmaceuticals, Inc.) and Managing Director at New Mountain Capital LLC. Mr. Moura is also on the board of 5 other companies. Mr. Moura previously occupied the position of Principal at McKinsey & Co., Inc. He received an MBA from Harvard Business School and an undergraduate degree from Harvard College.
Frederic Vanderhaegen Frederic Vanderhaegen is Executive Vice President-Europe Region at Avantor, Inc. In the past he occupied the position of Executive VP & Head-Life Sciences Business at Tecan Group AG, Vice President & General Manager-EMEA Division at Ortho-Clinical Diagnostics and Vice President-Sales for Beckman Coulter, Inc. He received an undergraduate degree from Universit�0�1�0�8 Libre de Bruxelles, an undergraduate degree from Haute �0�1‰cole Lucia de Brouck�0�1¨re and an MBA from Open University Malaysia.
Thomas Connolly Thomas Connolly is on the board of Union College (New York) and Avantor, Inc. He received an undergraduate degree from Union College (New York).
Eric A. McAllister Eric A. McAllister is Chief Human Resources Officer & Executive VP at Avantor, Inc. Mr. McAllister previously held the position of Senior Vice President-Human Resources for Westinghouse Electric Co. LLC, Senior Director-Human Resources at Microsoft Corp., Global Vice President-Human Resources at Danaher Corp., Principal at Watson Wyatt & Co. Holdings, Principal at Motorola, Inc., Principal at Accenture LLC and Chief Human Resources Officer & Vice President at Omniture, Inc. Mr. McAllister received an undergraduate degree from Brigham Young University and an MBA from Kellogg School of Management.
Corey Walker Corey Walker is EVP-Americas, Biomaterials & Advanced Technologies at Avantor, Inc. In his past career Mr. Walker occupied the position of Safety Manager at Southam & Associates, Inc., Global Vice President at Sperry Drilling Services and Global VP-Multichem Global Business Groups at Halliburton Energy Services, Inc. He received an undergraduate degree from Brigham Young University and an MBA from Harvard Business School.
Jonathan M. Peacock Founder of Arix Bioscience Plc, Jonathan M. Peacock currently holds the position of Non-Executive Chairman of Arix Bioscience Plc and Chairman of Bellerophon Therapeutics, Inc. He is also on the board of Onyx Pharmaceuticals, Inc., Los Angeles County Museum of Natural History, Avantor, Inc. and Socati Corp. In his past career Mr. Peacock occupied the position of Chief Financial Officer & Executive Vice President of Amgen, Inc. Chief Financial Officer, Director & Executive VP at Amgen Rockville, Inc. and Chief Financial Officer for Amgen Ventures LLC (both are subsidiaries of Amgen, Inc.), Partner at McKinsey & Co., Inc., Chief Financial & Administrative Officer at Novartis AG and Partner at PricewaterhouseCoopers LLP. He received a graduate degree from the University of St. Andrews.
Ashish K. Kulkarni Presently, Ashish K. Kulkarni is Chief Technology Officer & Executive VP at Avantor, Inc. He is also on the board of Biohealth Innovation, Inc. In his past career he was Chief Technology & Innovation Officer at Celanese Corp., Vice President-Global Engineering at United Technologies Corp., Process & Product Engineer at General Electric Co. and Vice President-Global Engineering at American Standard Cos., Inc. He received a doctorate from Rensselaer Polytechnic Institute and an undergraduate degree from Osmania University.
Michael Stubblefield Currently, Michael Stubblefield is President, Chief Executive Officer & Director at Avantor, Inc. and Chief Executive Officer for Avantor Performance Materials, Inc. (a subsidiary of Avantor, Inc.). In the past he held the position of VP & General Manager-Advanced Engineered Materials at Celanese Corp. Michael Stubblefield received an undergraduate degree from the University of Utah and an MBA from Texas A&M University-Corpus Christi.
Christi L. Shaw Ms. Christi L. Shaw is a Chief Executive Officer-Kite at Gilead Sciences, Inc. and a President-Bio Medicines & Senior Vice President at Eli Lilly & Co. She is on the Board of Directors at Avantor, Inc. Ms. Shaw was previously employed as a President by Novartis Pharmaceuticals Corp., a VP-New Business Development & Strategic Analytics by Ethicon Corp., a Group Product Director by Ortho-McNeil-Janssen Pharmaceuticals, Inc., and a Principal by Johnson & Johnson. She also served on the board at Biotechnology Innovation Organization, Healthcare Leadership Council and The Young Women's Leadership Network, Inc. She received her undergraduate degree from Iowa State University and an MBA from the University of Wisconsin.
Christophe Couturier Christophe Couturier is EVP-Services, Strategy & Business Transformation at Avantor, Inc. In his past career Mr. Couturier occupied the position of Chief Executive Officer of Salicornia LLC, Head-Finance for Novartis AG, Senior Vice President & General Manager at Merck KGaA, Finance Director for Lloyds Pharmacy Ltd., Chief Financial Officer of OvaScience, Inc. and Associate Partner at IBM Business Consulting Services, Inc. Christophe Couturier received an MBA from ESSEC Business School.
Devashish Ohri Devashish Ohri is on the board of Avantor Performance Materials India Ltd. and Executive Vice President-AMEA Region at Avantor, Inc. In the past he occupied the position of Managing Director-South Asia Region at Life Technologies, Inc. He received a graduate degree from the University of Delhi and an MBA from INSEAD.
Steven W. Eck Currently, Steven W. Eck is Chief Accounting Officer & Senior Vice President at Avantor, Inc. In his past career Mr. Eck was Chief Accounting Officer for CSS Industries, Inc. He received an undergraduate degree from Muhlenberg College.
Bjorn Hofman Presently, Bjorn Hofman is Chief Operating Officer & Executive Vice President for Avantor, Inc. Mr. Hofman previously occupied the position of Business Director-EMEA Region at Celanese Corp. and Senior Vice President-Advanced Technologies at Merck KGaA. Mr. Hofman received a graduate degree from Delft University of Technology.
Justin Miller Presently, Justin Miller occupies the position of Secretary, Executive VP & General Counsel of Avantor, Inc. In the past Mr. Miller held the position of Attorney at Ballard Spahr LLP and Associate General Counsel at E.I. du Pont de Nemours & Co. He received an undergraduate degree from the University of Pennsylvania and a graduate degree from George Mason University School of Law.
Michael Wondrasch Michael Wondrasch is Chief Information Officer & Executive VP for Avantor, Inc. In his past career he held the position of Vice President-Technology at AmerisourceBergen Corp., Global Chief Technology Officer at Bunge Ltd. and Chief Technology Officer & Senior Vice President for PepsiCo, Inc. He received an undergraduate degree from Villanova University and a graduate degree from the University of Pennsylvania.
Thomas Connolly Thomas Connolly is on the board of Union College (New York) and Avantor, Inc. He received an undergraduate degree from Union College (New York).
Jo Natauri Jo Natauri is on the board of Safe Horizon, Inc. and Avantor, Inc. Jo Natauri received an undergraduate degree from the University of Virginia.
James Bramwell James Bramwell is Executive Vice President-Strategic Partners at Avantor, Inc. In the past Mr. Bramwell was Senior VP-Strategic Partners & Global Export at VWR Corp. and President at VWR Foundation. Mr. Bramwell received an undergraduate degree from Brigham Young University.
Gerard Brophy Gerard Brophy is Executive Vice President-Biopharma Production at Avantor, Inc. Mr. Brophy received an undergraduate degree and a doctorate from Dublin City University.
Michael J. Depetris Currently, Michael J. Depetris occupies the position of Chief Audit Executive & Senior Vice President at Avantor, Inc.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐